ADOLESCENT AND ADULT POPULATIONS

Expert committee approves Bharat Biotech International's proposal to conduct Phase-2 trials of TB vaccine: Sources

​According to sources, in the minutes of the meeting of Subject Expert Committee (SEC) held on March 30, 2024, the firm presented Phase I clinical trial report with 28 days safety results along with Phase II clinical trial protocol titled, "A Phase II,